Hospira Inc. recalls Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1
Recalled December 31, 2014 · FDA recall D-0313-2015 · Hospira
Hazard
Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions. · FDA Class III
Units
3,306 vials
Sold at
Nationwide
Description
Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
Product
Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →